InnovAge (NASDAQ:INNV – Get Free Report) and Agilon Health (NYSE:AGL – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, dividends, valuation and profitability.
Analyst Ratings
This is a breakdown of current ratings and price targets for InnovAge and Agilon Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InnovAge | 1 | 1 | 1 | 1 | 2.50 |
| Agilon Health | 2 | 6 | 7 | 1 | 2.44 |
InnovAge presently has a consensus target price of $10.50, indicating a potential upside of 14.38%. Agilon Health has a consensus target price of $108.38, indicating a potential upside of 20.90%. Given Agilon Health’s higher possible upside, analysts plainly believe Agilon Health is more favorable than InnovAge.
Risk and Volatility
Institutional & Insider Ownership
12.3% of InnovAge shares are held by institutional investors. 1.1% of InnovAge shares are held by company insiders. Comparatively, 2.5% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares InnovAge and Agilon Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| InnovAge | 0.88% | 3.63% | 1.64% |
| Agilon Health | -1.45% | -51.97% | -7.15% |
Valuation & Earnings
This table compares InnovAge and Agilon Health”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InnovAge | $989.71 million | 1.27 | -$2.54 million | $0.06 | 153.00 |
| Agilon Health | $5.93 billion | 0.25 | -$391.35 million | ($5.55) | -16.15 |
InnovAge has higher earnings, but lower revenue than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than InnovAge, indicating that it is currently the more affordable of the two stocks.
Summary
InnovAge beats Agilon Health on 9 of the 14 factors compared between the two stocks.
About InnovAge
InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.
About Agilon Health
Agilon Health is a U.S. healthcare company that partners with primary care physicians to provide care for patients enrolled in Medicare Advantage plans. Its model is designed to help physician groups move from traditional fee-for-service care toward value-based care, in which providers are rewarded for improving patients’ health and coordinating their care. The company provides participating physician groups with clinical, operational, technology and administrative support, along with resources to manage patient populations and coordinate care across local healthcare networks.
Receive News & Ratings for InnovAge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InnovAge and related companies with MarketBeat.com's FREE daily email newsletter.
